メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
Keio University ホーム
ヘルプ&FAQ
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
臨床検査医学
医学部
医学部臨床教室
概要
フィンガープリント
ネットワーク
プロファイル
(6)
研究成果
(330)
フィンガープリント
臨床検査医学が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine & Life Sciences
SARS Virus
100%
Japan
88%
Mycobacterium avium Complex
80%
Blood Platelets
78%
Coronavirus
74%
Lung
59%
Pulmonary Hypertension
58%
Platelet Glycoprotein GPIb-IX Complex
56%
Lung Diseases
54%
Infections
50%
von Willebrand Factor
47%
Transcatheter Aortic Valve Replacement
46%
Balloon Angioplasty
44%
Vaccination
44%
Severe Acute Respiratory Syndrome
43%
Antibodies
35%
Genes
34%
Serum
33%
Genotype
32%
Therapeutics
31%
Platelet Membrane Glycoproteins
30%
Aspirin
30%
Three-Dimensional Echocardiography
29%
Acute Promyelocytic Leukemia
28%
Echocardiography
28%
Platelet Aggregation
28%
Megakaryocytes
26%
Mutation
26%
Hematopoietic Stem Cell Transplantation
26%
Thrombotic Thrombocytopenic Purpura
26%
University Hospitals
24%
Aortic Valve Insufficiency
24%
Health Personnel
24%
Population
24%
Cross-Sectional Studies
24%
Tokyo
24%
Migraine Disorders
24%
riociguat
24%
Cellular Immunity
24%
Right Ventricular Function
24%
Neoplasms
24%
Standing Position
23%
Hemodynamics
23%
Polymerase Chain Reaction
22%
Transesophageal Echocardiography
22%
Vaccines
22%
Observational Studies
22%
Anticoagulants
22%
In Vitro Techniques
22%
Chronic Obstructive Pulmonary Disease
21%
Cerebrovascular Disorders
21%
Thrombosis
21%
human MIRN346 microRNA
21%
Incidence
20%
Homologous Transplantation
20%
Bone Marrow Transplantation
20%
Supine Position
20%
Liposomes
20%
Obstructive Sleep Apnea
20%
Odds Ratio
20%
Hematology
20%
Stroke Volume
19%
Elderly
19%
Confidence Intervals
18%
Tretinoin
18%
Coronary Artery Disease
18%
Integrins
18%
Antithrombins
18%
Tomography
18%
fremanezumab
18%
Cell Line
17%
Cohort Studies
17%
Idiopathic Thrombocytopenic Purpura
17%
Myeloid Cells
17%
Pneumocystis Pneumonia
17%
Mycobacterium abscessus
17%
Epitopes
17%
Pulmonary Arterial Hypertension
16%
Mitral Valve Insufficiency
16%
Genetic Polymorphisms
16%
Acquired Thrombotic thrombocytopenic purpura
16%
Primary Prevention
16%
Mycobacterium
16%
Bone Marrow
16%
Neutralizing Antibodies
16%
galcanezumab
16%
Alleles
15%
Humoral Immunity
15%
Monoclonal Antibodies
15%
Autoantibodies
15%
Acute Lung Injury
15%
polyglucosan
15%
Thrombopoietin
15%
Liver
15%
Fibrinogen
14%
Immunoglobulin G
14%
Pneumonia
14%
Stem Cells
14%
Single Nucleotide Polymorphism
14%
Bacteremia
14%